Search results

Aim: Previous research has documented the widespread use of antipsychotic drugs by nursing staff with older persons, although less is known about the knowledge that nurses actually have about these drugs. The purpose of this exploratory, descriptive study was to survey a sample of UK gerontological nurses from different work settings on their knowledge of antipsychotic drugs.Methods: An exploratory descriptive study design was utilised, whereby a sample of nursing staff was given a questionnaire developed to determine knowledge about antipsychotic drugs and their use with older persons. Questionnaires were distributed to 100 nursing staff, including registered general nurses, registered mental nurses, state enrolled nurses, nursing assistants and care assistants. Of the 100 questionnaires distributed, 62 were returned and 57 were completed substantially enough for data analysis.Results: Descriptive statistics including frequencies and means were calculated for demographic variables and the questionnaire responses. Results indicated that the use of antipsychotic drugs within the psychiatric hospital setting was substantial, with 43.7% of patients receiving antipsychotic drugs, for an average length of time of 1.8 years. Conclusions: Nursing staff participants from all three work settings revealed a number of significant knowledge gaps, particularly with regard to appropriate indications for antipsychotic drugs with older persons and the side‐effects of antipsychotic drugs. Summary: This paper adds new information regarding the use of antipsychotic drugs in the nursing care of older people.

Antipsychotic drugs are often used outside their licensed indication to manage aggression in adults with intellectual disabilities in the absence of a diagnosed psychiatric disorder. The current case series shows that antipsychotics could be effective, but they are often used with non‐drug measures and sometimes cause side‐effects. Clinicians did not always carry out a thorough assessment followed by a formulation before prescribing medications, as recommended in the national and international guides (Deb et al, 2009; Unwin & Deb, 2010). It is also apparent that clinicians did not carry out tests to detect side‐effects of risperidone such as metabolic syndrome. Clinicians should use psychotropic medication for a minimum period of time and at the lowest possible dose, and should consider non‐drug management of aggression at the outset and at a regular interval.

Telecommuting from home is back up on the agenda as a result of the unforeseen challenges brought by COVID-19. Working from home permits to avoid disruption in the ordinary functioning of educational institutions triggered by social distancing. However, home-based telecommuting may have some side effects on employees, especially in terms of work-life balance. Soft Total Quality Management (TQM) initiatives are needed to address these side effects. The article intends to shed light on these issues, providing some food for thought to scholars and practitioners.

Secondary data about the working conditions of 2,046 people employed in the education sector across Europe were investigated. A serial mediation analysis was designed to examine the direct and indirect implications of working from home on work-life balance.

The study suggests that home-based telecommuting may trigger work-to-life and life-to-work conflicts, due to the blurring of boundaries between work and everyday life. Soft tools, such as organizational meaningfulness (OM) and work-related well-being (WB), mediate the relationship between working from home (HW) and work-life conflicts (WLC), lessening the negative implications of working from home on work-life balance.

The design and the implementation of home-based telecommuting arrangements should include a special concern for soft TQM practices. Among others, OM and WB are likely to minimize the disruption of remote employees' jobs and interpersonal relationships. Failure to do so impairs the ability of home-based employees to make sense out of their working arrangements and to achieve a sustainable work-life balance.

This is one of the first attempts to illuminate the side effects of home-based telecommuting and to investigate the role of soft TQM in addressing these side effects.

Organizational change (OC) triggers uncertainty and ambiguity, which have side effects for individual and groups. Even though scholars and practitioners have generally conceived OC as a remedy for workplace discrimination (WD), it may determine opportunistic behaviors, which increase the risks of discrimination at work. The article discusses the direct and indirect effects of OC on WD, investigating the moderating role of organizational meaningfulness (OM) and employees' involvement (EI).

Secondary data were collected from the Eurofound's European Working Conditions Survey (EWCS). The sample included 33,024 European employees. A double moderation analysis based on the bootstrapping method was designed to collect evidence on the direct effects of OC on WD and on the indirect effects moderated by OM and EI.

OC was found to generate greater discrimination at work. People who were not informed about change and those who were not allowed to express their opinion about change were more likely to report discrimination. OM and EI performed as significant moderators of the side effects of OC on WD.

Restructurings and reorganizations are tricky processes. The uncertainty and ambiguity produced by OC might negatively affect interpersonal relationships at work and organizational practices, paving the way for overt and/or explicit discrimination. The construction of clear and shared senses around change is crucial to curb the drawbacks of organizational transitions on workplace discrimination. EI is essential to improve organizational sensemaking of change processes and to establish a positive organizational climate, which prevent the occurrence of WD.

Literature has overlooked the negative implications of OC on WD. The study findings emphasize that organizational transitions may trigger discrimination, creating greater uncertainty and ambiguity in the workplace. OM and EI allow overcoming ambiguity and increase the employees' ability to deal with uncertainty, addressing the side effects of OC on WD.

Telemarketing has added a new medium to the marketer's bag of tricks. This article briefly discusses the benefits and limitations of telemarketing as part of an overall marketing campaign. It then proceeds to discuss (via some new findings) the potential side effects that telemarketing may have on the image of the firm using it.

This study investigates the prescription of antimuscarinic medication and the opinions of qualified psychiatric nursing staff regarding the use of ‘as required’ antimuscarinic drugs at a large secure psychiatric unit. No instances of inappropriate prescribing of antimuscarinic agents were found.

This paper aims to summarize the available literatures, specifically in the following areas: metabolic and other side effects of aspartame; microbiota changes/dysbiosis and its effect on the gut-brain axis; changes on gut microbiota as a result of aspartame usage; metabolic effects (weight gain and glucose intolerance) of aspartame due to gut dysbiosis; and postulated effects of dysregulated microbiota-gut-brain axis on other aspartame side-effects (neurophysiological symptoms and immune dysfunction).

Aspartame is rapidly becoming a public health concern because of its purported side-effects especially neurophysiological symptom and immune dysregulation. It is also paradoxical that metabolic consequences including weight gain and impaired blood glucose levels have been observed in consumers. Exact mechanisms of above side-effects are unclear, and data are scarce but aspartame, and its metabolites may have caused disturbance in the microbiota-gut-brain axis.

Additional studies investigating the impact of aspartame on gut microbiota and metabolic health are needed.

Exact mechanism by which aspartame-induced gut dysbiosis and metabolic dysfunction requires further investigation.

The purpose of this paper is to identify and evaluate the potential cooling contribution provided by a phase change material cooling vest as part of the total heat exchange mechanism of the body and take in to account the negative side effects of wearing the cooling garments.

In this study, the three-part system of body-garment-environment has been simulated through the finite element method and the problem of heat exchange between these three parts has been solved with the help of computer modeling.

The results of this modeling showed that a large percentage of the cooling efficiency of cooling vest was neutralized by the negative effects of the vest that are weight, lack of breathability, and the effects on the thermal conductivity of the skin. Therefore, the net efficiency of the cooling vests resulted in a lower decrease in skin temperature compared to the state that the negative side effects were not included in the model.

Cooling power obtained with the help of cooling garments have been studied in previous studies using either human tests or manikins. But, what has been addressed less in previous studies relates to the negative effects of such equipment on the comfort of body, along with their cooling effect. So it is the first time witch the effect of side effects of such equipments are studied. Also modeling the real performance of cooling garments have not been done yet.

Financial‐ and growth‐oriented marketing objectives of traditional marketers have been criticized by marketing ethicists, because these objectives may lead to socially irresponsible marketing practices. Marketing based on the quality‐of‐life (QOL) concept posits that marketers should strive to enhance consumers’ wellbeing without harming other publics or stakeholders. Shows how marketing managers can set marketing objectives based on the QOL concept to guide socially responsible marketing practices. Develops a conceptual framework for setting marketing objectives. The framework shows that marketing managers with a QOL frame of mind should first examine the marketing policies that have been criticized by marketing ethicists. Second, marketing managers should logically drive specific marketing mix objectives based on the QOL concept. Third, general marketing objectives should be deduced from the marketing mix objectives for socially responsible marketing.

Great controversy surrounds the prescribing of antipsychotics for people with an intellectual disability. This stems from a lack of research to support their use in this specific population together with their “off label” use to treat behaviour problems. This paper aims to review prescribing practice of antipsychotics by the Salford Intellectual Disability Psychiatry Department in accordance with standards adapted from nationally recognised guidelines.

Data was collected from all 178 patients under this department including patient demographics, severity of intellectual disability, co‐morbid diagnoses and details of any antipsychotic drug use. Main standards of prescribing measured: indication of antipsychotic prescribing; documented review of medications; documentation of side effects; documentation of physical health parameters including weight, blood pressure, blood glucose, lipids.

In total, 126 (72 per cent) were prescribed antipsychotics. 42 (33 per cent of these were for challenging behaviour. 91 (72 per cent) had indication documented. 123 (98 per cent) of prescriptions had been reviewed. There was not very regular documentation of side effects and physical parameters for monitoring metabolic syndrome.

Data was taken from all patients under the care of Salford Intellectual Disability Psychiatric team therefore eliminating sampling bias. The audit findings will be of value to other UK urban psychiatry departments as they should be highly representative of a wider population of patients. The authors are already aware of lack of evidence in use of antipsychotic medication for treating challenging behaviours in patients with learning disability.

This study confirms the use of antipsychotics in management of challenging behaviours in this population as a third of the sample population was being treated with antipsychotics for behaviour problems. The study also shows that there was lack of documentation of physical health and side effect monitoring. It highlights that there should be regular monitoring of physical and side effects with careful documentation.